Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Petit

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Nanotoxicology|November 26, 2013
Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell linesV Paget, J A Sergent, R Grall, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignanciesM A Villalona-Calero, T Petit, J Kuhn, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
Journal of Human Hypertension|August 8, 2014
The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white EuropeansL Olivi, Y M Gu, E Salvi, et al.
Breast Cancer Research and Treatment|December 23, 2022
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancerH Bischoff, C Bigot, F Moinard-Butot, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Nanotoxicology|November 26, 2013
Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell linesV Paget, J A Sergent, R Grall, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignanciesM A Villalona-Calero, T Petit, J Kuhn, et al.
Bulletin Du Cancer|July 1, 1996
[Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]T Petit, P Dufour, J C Barrats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
Journal of Human Hypertension|August 8, 2014
The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white EuropeansL Olivi, Y M Gu, E Salvi, et al.
Breast Cancer Research and Treatment|December 23, 2022
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancerH Bischoff, C Bigot, F Moinard-Butot, et al.
Pageof 16